Page last updated: 2024-12-06

magnolol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Magnolol is a natural biphenolic compound found in the bark of Magnolia officinalis, a traditional Chinese medicinal herb. It has been shown to possess various pharmacological properties, including antioxidant, anti-inflammatory, and neuroprotective effects. Magnolol has been investigated for its potential therapeutic applications in conditions such as Alzheimer's disease, stroke, cancer, and diabetes. The synthesis of magnolol involves various methods, including chemical synthesis and biotransformation. Research on magnolol continues due to its promising biological activities and potential applications in various fields of medicine.'

FloraRankFlora DefinitionFamilyFamily Definition
MagnoliagenusA plant genus of the family MAGNOLIACEAE. The germacranolide sesquiterpene lactones costunolide, parthenolide, and costunolide diepoxide have been isolated from the leaves. Bark contains honokiol and magnolol. Parts are an ingredient of Banxia Houpo Tang.[MeSH]MagnoliaceaeA plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals (sepals and petals that are not distinctly different) and many spirally arranged stamens.[MeSH]
Magnolia obovataspecies[no description available]MagnoliaceaeA plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. They are trees and shrubs having an elongated conelike floral axis with fragrant flowers that have six tepals (sepals and petals that are not distinctly different) and many spirally arranged stamens.[MeSH]

Cross-References

ID SourceID
PubMed CID72300
CHEMBL ID180920
CHEBI ID6643
SCHEMBL ID132477
MeSH IDM0047073

Synonyms (76)

Synonym
AC-931
smr000387108
MLS001048917 ,
nsc 293099
5,5'-diallyl-2,2'-dihydroxybiphenyl
(1,1'-biphenyl)-2,2'-diol, 5,5'-di-2-propenyl-
nsc-293099
nsc293099
SMP2_000086
2,2'-bichavicol
5,5'-di-2-propenyl-[1,1'-biphenyl]-2,2'-diol
4-allyl-2-(5-allyl-2-hydroxy-phenyl)phenol
dehydrodichavicol
UPCMLD-DP037:001
magnolol ,
528-43-8
magnolol, >=95% (hplc), from plant
UPCMLD-DP037
NCGC00161609-01
NCGC00161609-02
5,5'-di(prop-2-en-1-yl)biphenyl-2,2'-diol
BRD-K26168087-001-01-4
2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol
CHEMBL180920
chebi:6643 ,
STK801955
AKOS005266409
A829277
5,5'-diallyl-[1,1'-biphenyl]-2,2'-diol
HMS2269N09
unii-001e35hgvf
001e35hgvf ,
hsdb 7686
2'-bichavicol
5,5'-diallyl-2,2'-biphenyldiol
FT-0628104
5,5'-di-2-propen-1-yl-(1,1'-biphenyl)-2,2'-diol
magnolol [inci]
fema no. 4559
magnolol [hsdb]
magnolol [mi]
2,2'-dihydroxy-5,5'-diallylbiphenyl
S2321
CCG-208588
SCHEMBL132477
BBL027818
2-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol
2-(2-oxidanyl-5-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol
cid_72300
bdbm78304
CS-5021
REGID_FOR_CID_72300
DTXSID0044076
5,5 inverted exclamation mark -diallyl-2,2 inverted exclamation mark -biphenyldiol
SY016075
mfcd00016658
5,5'-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
DS-1284
Q-100598
[1,1'-biphenyl]-2,2'-diol, 5,5'-di-2-propenyl-
HY-N0163
5,5'-diallylbiphenyl-2,2'-diol
D3971
SR-01000758206-4
SR-01000758206-3
sr-01000758206
HMS3651O18
magnolol, european pharmacopoeia (ep) reference standard
SW219728-1
[1,1'-biphenyl]-2,2'-diol, 5,5'-di-2-propen-1-yl-
magnolol,(s)
BCP28276
Q6732002
AMY40661
EN300-7368364
Z1741977128

Research Excerpts

Overview

Magnolol is a multifunctional polyphenol with antioxidant, anti-inflammatory, anticancer and neuroprotective functions. It is a component of the bark of Magnolia officinalis, a traditional herbal remedy used in China.

ExcerptReferenceRelevance
"Magnolol is a multifunctional polyphenol with antioxidant, anti-inflammatory, anticancer and neuroprotective functions."( Maternal magnolol supplementation alters placental morphology, promotes placental angiogenesis during mid-gestation and improves offspring growth in a pregnant mouse model.
Chen, F; Chen, M; Du, E; Fan, Q; Guo, W; Huang, S; Wei, J; Yan, X; Zhang, W; Zhao, N, 2021
)
1.76
"Magnolol is an active component isolated from Magnolia officinalis with potential neuroprotection activity."( Magnolol upregulates CHRM1 to attenuate Amyloid-β-triggered neuronal injury through regulating the cAMP/PKA/CREB pathway.
Cui, X; Fang, Y; Jia, R; Kang, X; Zhao, R; Zhu, G, 2022
)
2.89
"Magnolol is a multifunctional polyphenol rich in Magnolia officinalis. "( Supplemental magnolol improves the antioxidant capacity and intestinal health of broiler chickens.
Chen, F; Du, E; Fan, Q; Guo, W; Huang, S; Wei, J; Zhang, W; Zhao, N,
)
1.94
"Magnolol is a bioactive polyphenolic compound commonly found in Magnolia officinalis. "( Magnolol additive improves growth performance of Linwu ducklings by modulating antioxidative status.
Dai, Q; Fan, Z; He, X; Li, Y; Liao, L; Lin, Q; Liu, C; Liu, Y; Lv, T; Peng, S; Qiu, H; Wang, Y; Wu, W; Zeng, J, 2021
)
3.51
"Magnolol is a component of the bark of Magnolia officinalis, which is a traditional herbal remedy used in China. "( Magnolol reduces myocardial injury induced by renal ischemia and reperfusion.
Chiang, SC; Huang, CH; Huang, PC; Huang, PH; Lai, CC; Tang, CY; Tseng, KW; Yang, AH, 2022
)
3.61
"Magnolol is a botanical antibiotic, but poor physicochemical properties result in low bioavailability."( Mechanosynthesis of magnolol multicomponent crystalline solids for improved natural antibiotics and customizable release profiles.
Gong, J; Li, Z; Qu, H; Wu, S, 2023
)
1.96
"Magnolol is a biologically active compound, isolated from the Chinese herb "( Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells.
Kwon, TK; Min, KJ; Woo, SM, 2020
)
3.44
"Magnolol is an effective component against various cancers."( Magnolol suppressed cell migration and invasion and induced cell apoptosis via inhibition of the NF-κB signaling pathway by upregulating microRNA-129 in multiple myeloma.
Jin, W; Lan, Y; Wang, X; Zeng, Y, 2021
)
2.79
"Magnolol is a multifunctional plant polyphenol. "( Effects of magnolol on egg production, egg quality, antioxidant capacity, and intestinal health of laying hens in the late phase of the laying cycle.
Chen, F; Du, E; Fan, Q; Guo, W; Huang, S; Jin, F; Wei, J; Zhang, H; Zhang, W; Zhao, N; Zheng, C, 2021
)
2.45
"Magnolol is a biphenol compound rich in the stem bark of Magnolia officinalis Rehd et Wils., and is able to suppress viral replication in GCRV-infected grass carp (Ctenopharyngodon idella) kidney (CIK) cells in the previous study."( Magnolol protects Ctenopharyngodon idella kidney cells from apoptosis induced by grass carp reovirus.
Chen, X; Hao, K; Huang, A; Ling, F; Wang, GX; Yu, X; Zhu, B, 2018
)
2.64
"Magnolol is a major bioactive compound derived from the plant species Magnolia officinalis."( Magnolol Nanoparticles Exhibit Improved Water Solubility and Suppress TNF-α-Induced VCAM-1 Expression in Endothelial Cells.
Chiang, YC; Hsu, LF; Hu, SC; Huang, CL; Lee, CW; Lee, IT; Liang, CJ; Lin, ZC; Tsai, MH; Yen, FL, 2017
)
2.62
"Magnolol is a natural compound from Magnolia officinalis suggested to have antiproliferative activity."( Magnolol Inhibits Human Glioblastoma Cell Migration by Regulating N-Cadherin.
Chen, Y; Cheng, YC; Chiu, CY; Kan, PC; Tsao, MJ, 2018
)
2.64
"Magnolol is a hydroxylated biphenyl isolated from the root and stem bark of Magnolia tree."( Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer.
Banik, K; Deshpande, V; Fan, L; Kumar, AP; Kunnumakkara, AB; Padmavathi, G; Ranaware, AM; Roy, NK; Sethi, G, 2018
)
2.64
"Magnolol is a natural extract and the main bioactive component from Chinese medicine-Magnolia. "( Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-κB signal pathways in vitro and in vivo.
Chen, H; Fu, W; Huang, J; Liu, X; Rui, W; Wei, Y; Yang, Y; You, S, 2019
)
3.4
"Magnolol is a compound that is extracted from magnolia, is used in Chinese medicine and is a type of lignan. "( Magnolol prevents ossified tendinopathy by inhibiting PGE2-induced osteogenic differentiation of TDSCs.
Chu, J; Jiang, T; Lin, X; Yan, B; Zhang, Z; Zhao, H; Zhou, W, 2019
)
3.4
"Magnolol is a traditional Chinese medicine from the root and bark of Magnolia officinalis. "( Magnolol inhibits tumor necrosis factor-α-induced ICAM-1 expression via suppressing NF-κB and MAPK signaling pathways in human lung epithelial cells.
Chunlian, W; Gentao, L; Heyong, W; Jia, X; Jie, H; Xi, C, 2014
)
3.29
"Magnolol is a polyphenolic binaphthalene compound extracted from the stem bark of Magnolia sp., which has been shown to exert a potential for anti-inflammatory activity."( Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model.
Dejie, L; Naisheng, Z; Tiancheng, W; Wei, W; Xiaojing, S; Yongguo, C; Zhengtao, Y, 2015
)
2.58
"Magnolol is an anti-oxidant compound extracted from the cortices of Magnolia officinalis."( Magnolol depresses urotensin-II-induced cell proliferation in rat cardiac fibroblasts.
Chen, JJ; Chen, PY; Chen, YL; Cheng, TH; Hong, CY; Liou, JY; Liu, JC; Loh, SH, 2009
)
2.52
"Magnolol is a compound extracted from the Chinese medicinal herb Magnolia officinalis. "( Beneficial effects of magnolol in a rodent model of endotoxin shock.
Cheng, PY; Ke, TH; Kung, CW; Peng, YJ; Tsai, YC; Wang, JJ; Yen, MH, 2010
)
2.12
"Magnolol (M) is a polyphenol antioxidant abundant in the bark of Magnolia officinalis Rehder & E. "( Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats.
Chen, YC; Hou, YC; Lee Chao, PD; Lin, SP; Tsai, SY, 2011
)
2.05
"Magnolol is a potent antioxidant."( Magnolol attenuates the lung injury in hypertonic saline treatment from mesenteric ischemia reperfusion through diminishing iNOS.
Huang, MS; Lee, CH; Shih, HC, 2012
)
2.54
"Magnolol is a food additive that is often found in mints and gums. "( Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Dong, P; Fang, Z; Finel, M; Ge, G; He, G; Liang, S; Liu, H; Yang, L; Zhang, H; Zhang, Y; Zhu, L, 2012
)
2.06
"Magnolol also serves as an smooth muscle relaxant only upon the high concentration."( Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.
Ho, JH; Hong, CY, 2012
)
1.39
"Magnolol is a Chinese herb that has potent antioxidant effects. "( Magnolol alters cytokine response after hemorrhagic shock and increases survival in subsequent intraabdominal sepsis in rats.
Lee, CH; Shih, HC; Wei, YH, 2003
)
3.2
"1. Magnolol is an active component of Magnolia officinalis. "( Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation.
Hong, CY; Huang, SS; Tsai, SK, 1996
)
2.36
"Magnolol is a compound extracted from the Chinese medicinal herb Magnolia officinalis and has multiple pharmacological effects, notably antioxidant functions."( Magnolol attenuates peroxidative damage and improves survival of rats with sepsis.
Chan, WL; Chin, JH; Hong, CY; Kong, CW; Tsai, K, 2000
)
2.47
"Magnolol is an active component purified from Magnolia officinalis that has been reported to protect the myocardium against infarction and reperfusion injury. "( Effect of magnolol on coronary vascular resistance in rabbits: measurement with pulsed Doppler velocimetry.
Hong, CY; Huang, CH; Lai, ST; Tsai, SK, 2000
)
2.15
"Magnolol is an 11beta-hydroxysteroid dehydrogenase (11beta-HSD) inhibitor contained in Magnolia officinalis which is used in Chinese remedies. "( Magnolol from Magnolia officinalis inhibits 11beta-hydroxysteroid dehydrogenase without increases of corticosterone and thymocyte apoptosis in mice.
Hayashi, T; Hiran, T; Homma, M; Horigome, H; Niitsuma, T; Oka, K, 2001
)
3.2
"Magnolol is an antiplatelet agent isolated from Chinese herb Magnolia officinalis. "( EDRF-release and Ca+(+)-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta.
Chen, CC; Huang, TF; Huang, YL; Teng, CM; Yu, SM, 1990
)
1.98

Effects

Magnolol has an antitumor effect by increasing E-cadherin and miRNA-200c-3p expression to regulate ZEB1-mediated EMT and cancer progression in retinoblastoma. Magnolol, therefore, has a potential application in preventing atherosclerosis and restenosis.

Magnolol has shown the potential anticancer properties against a variety of cancers. It has been proved to have several pharmacological properties including anti-bacterial, anti-oxidant and anti-inflammatory. Magnolol, therefore, has a potential application in preventing atherosclerosis and restenosis.

ExcerptReferenceRelevance
"Magnolol has a significant anti-tumor effect on various cancers."( Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Chang, YC; Chen, IL; Chen, YH; Hsieh, CC; Huang, CY; Kuo, CW; Kuo, HF; Lai, YH; Lee, PY; Lee, TY; Li, CY; Liu, CC; Liu, PL; Liu, WL; Liu, YR; Lo, J; Wang, SC; Wu, SH, 2023
)
3.07
"Magnolol has an antitumor effect by increasing E-cadherin and miRNA-200c-3p expression to regulate ZEB1-mediated EMT and cancer progression in retinoblastoma. "( Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Chang, YC; Chen, IL; Chen, YH; Hsieh, CC; Huang, CY; Kuo, CW; Kuo, HF; Lai, YH; Lee, PY; Lee, TY; Li, CY; Liu, CC; Liu, PL; Liu, WL; Liu, YR; Lo, J; Wang, SC; Wu, SH, 2023
)
3.8
"Magnolol, therefore, has a potential application in preventing atherosclerosis and restenosis."( Role of magnolol in the proliferation of vascular smooth muscle cells.
Dong, Q; Wang, L; Wu, L; Xia, W; Zou, H, 2015
)
1.57
"Magnolol has an anti-apoptotic effect and protects the liver against WI/R for 2 h but not for 3 h through upregulation of the anti-apoptotic Bcl-XL gene and suppression of the Bcl-xS gene."( The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver.
Chen, CL; Chen, YS; Cheng, YF; Eng, HL; Goto, S; Hsieh, SW; Jawan, B; Lai, CY; Lan, KM; Lin, YC; Luk, HN; Pan, TL; Wang, CC, 2003
)
2.06
"Magnolol has a significant anti-tumor effect on various cancers."( Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Chang, YC; Chen, IL; Chen, YH; Hsieh, CC; Huang, CY; Kuo, CW; Kuo, HF; Lai, YH; Lee, PY; Lee, TY; Li, CY; Liu, CC; Liu, PL; Liu, WL; Liu, YR; Lo, J; Wang, SC; Wu, SH, 2023
)
3.07
"Magnolol has an antitumor effect by increasing E-cadherin and miRNA-200c-3p expression to regulate ZEB1-mediated EMT and cancer progression in retinoblastoma. "( Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Chang, YC; Chen, IL; Chen, YH; Hsieh, CC; Huang, CY; Kuo, CW; Kuo, HF; Lai, YH; Lee, PY; Lee, TY; Li, CY; Liu, CC; Liu, PL; Liu, WL; Liu, YR; Lo, J; Wang, SC; Wu, SH, 2023
)
3.8
"Magnolol, a neolignan, has been known for its apoptotic role in glioma."( Magnolol induces cytotoxic autophagy in glioma by inhibiting PI3K/AKT/mTOR signaling.
Das, CK; Das, S; Dhara, D; Kulkarni, G; Kundu, M; Mandal, M, 2023
)
3.07
"Magnolol has been known to possess anti-inflammatory and anti-oxidant activities in various tissues, but its effects on gingival cells under diabetic conditions have not been fully understood."( Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis.
Chen, SH; Hsieh, PL; Liao, YW; Liu, CM; Yu, CC; Yu, CH, 2021
)
2.79
"Magnolol has shown the potential anticancer properties against a variety of cancers. "( Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
Ren, HY; Shen, DY; Shen, JX; Ye, HM; Zhang, FH; Zhang, XY, 2017
)
3.34
"Magnolol has been proved to have several pharmacological properties including anti-bacterial, anti-oxidant and anti-inflammatory activities."( Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage.
Cao, Y; Gu, C; He, Y; Li, S; Li, Y; Liu, J; Lu, X; Shen, P; Zhang, N; Zhang, Z; Zhu, K, 2018
)
2.64
"Magnolol has various anti-inflammation, anti-proliferation and pro-autophagy effects."( Magnolol prevents ossified tendinopathy by inhibiting PGE2-induced osteogenic differentiation of TDSCs.
Chu, J; Jiang, T; Lin, X; Yan, B; Zhang, Z; Zhao, H; Zhou, W, 2019
)
2.68
"Magnolol, therefore, has a potential application in preventing atherosclerosis and restenosis."( Role of magnolol in the proliferation of vascular smooth muscle cells.
Dong, Q; Wang, L; Wu, L; Xia, W; Zou, H, 2015
)
1.57
"Magnolol has shown inhibitory effects on NO production and TNF-alpha production in lipopolysaccharide (LPS)-activated macrophages and LPS-induced acute lung injury; however, the poor solubility of magnolol has hindered its clinical success. "( Protective effect of magnolol-loaded polyketal microparticles on lipopolysaccharide-induced acute lung injury in rats.
Chou, CL; Chou, TC; Kao, CY; Liu, LC; Tsai, T, 2016
)
2.2
"Magnolol has been reported to strongly inhibit the mutagenicity induced by indirect mutagens in the Ames test as well as the clastogenicity induced by benzo(a)pyrene (B(a)P) in the mice micronucleus test. "( Inhibitory effect of magnolol on Trp-P-2-induced DNA damage in various organs in mice.
Fukushima, H; Nagase, H; Saito, J, 2009
)
2.11
"Magnolol has been reported to have an anti-inflammatory and antitumor effect in vitro and in vivo. "( Inhibitory effect of magnolol on TPA-induced skin inflammation and tumor promotion in mice.
Cheng, AC; Kuo, DH; Lai, YS; Lo, CY; Pan, MH; Wu, H, 2010
)
2.12
"Magnolol has been reported to have anticancer property."( Anticancer potential of magnolol for lung cancer treatment.
Jeong, HJ; Kim, HM; Kim, MH; Seo, JU, 2011
)
1.4
"Magnolol has been reported to exhibit anti-tumor activities."( Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Cheng, YT; Chuang, TC; Fang, GS; Hsu, SC; Ou, CC; Shao, WS; Wang, V; Wu, K, 2011
)
2.53
"Magnolol has an anti-apoptotic effect and protects the liver against WI/R for 2 h but not for 3 h through upregulation of the anti-apoptotic Bcl-XL gene and suppression of the Bcl-xS gene."( The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver.
Chen, CL; Chen, YS; Cheng, YF; Eng, HL; Goto, S; Hsieh, SW; Jawan, B; Lai, CY; Lan, KM; Lin, YC; Luk, HN; Pan, TL; Wang, CC, 2003
)
2.06
"Magnolol has neurotrophic effects in primary cultured rat cortical neurons, which are expressed as the promotion of neurite outgrowth and neuronal survival. "( Neurotrophic effect of magnolol in the hippocampal CA1 region of senescence-accelerated mice (SAMP1).
Akagi, M; Akagi, R; Fukuishi, N; Fukuyama, Y; Matsui, N; Nakade, K; Nakashima, H; Shirono, A; Tada, T; Ushio, Y; Yasui, Y; Zhai, H, 2005
)
2.08
"Magnolol has been reported to have an inhibitory effect on tumor invasion in vitro and in vivo. "( Magnolol-induced apoptosis is mediated via the intrinsic pathway with release of AIF from mitochondria in U937 cells.
Akao, Y; Ikai, T; Nakagawa, Y; Nozawa, Y; Ohguchi, K; Sakai, Y, 2006
)
3.22
"Magnolol has been reported to play a role in antitumor activity. "( Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Cho, YH; Jung, KH; Kim, EJ; Kim, WJ; Lee, SJ; Moon, SK; Park, K; Park, SS, 2008
)
3.23
"Magnolol has been considered to be an active component of Saiboku-To as an inhibitor of 11 beta-hydroxysteroid dehydrogenase and T-lymphocyte proliferation resulting in corticosteroid-sparing."( Impact of free magnolol excretions in asthmatic patients who responded well to saiboku-to, a Chinese herbal medicine.
Homma, M; Itoh, H; Kobayashi, H; Niitsuma, T; Oka, K; Takahashi, N; Yamamoto, S, 1993
)
1.36
"Magnolol has been reported to have anticancer activity. "( Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells.
Chang, YT; Ho, YS; Lee, WS; Lee, YH; Lin, SY; Liu, JD; Yu, CH, 2001
)
2.01

Actions

Magnolol could inhibit the growth, migration and invasion of CCA cells through regulation of NF-κB pathway. Magnolol stimulated increase in the probability of channels opening was independent of internal Ca2+.

ExcerptReferenceRelevance
"Magnolol could inhibit the growth, migration and invasion of CCA cells through regulation of NF-κB pathway, and these data indicate that magnolol is a potential candidate for treating of CCA."( Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.
Ren, HY; Shen, DY; Shen, JX; Ye, HM; Zhang, FH; Zhang, XY, 2017
)
3.34
"The magnolol stimulated increase in the probability of channels opening was independent of internal Ca2+."( Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol.
Chen, CC; Chen, SA; Chiang, HT; Li, HF; Lo, YK; Wu, SN, 2002
)
1.02

Treatment

Pretreatment with magnolol prior to antimycin A exposure significantly reduced osteoblast dysfunction by preventing MMP dissipation, ATP loss, and CREB inactivation. Magnolol treatment significantly inhibited oxidative stress by reducing malondialdehyde (MDA) and nitric oxide production.

ExcerptReferenceRelevance
"Magnolol treatment significantly inhibited oxidative stress by reducing malondialdehyde (MDA), nitric oxide (NO) production, and myeloperoxidase (MPO) activity while enhancing the level of antioxidants such as reduced glutathione (GSH), glutathione-S-transferase (GST), catalase, and superoxide dismutase (SOD) in the brain and spinal cord."( Magnolol prevented brain injury through the modulation of Nrf2-dependent oxidative stress and apoptosis in PLP-induced mouse model of multiple sclerosis.
Ali, H; Bibi, T; Khan, A; Khan, AU; Khan, S; Seo, EK; Shal, B, 2022
)
2.89
"Magnolol treatment effectively inhibited cell proliferation and colony formation of NSCLC cells. "( Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
Hu, M; Li, G; Li, H; Liu, H; Ma, H; Shen, J; Yu, L; Zhang, T, 2017
)
3.34
"Magnolol pretreatment prevented sepsis-induced decreases in c-kit phosphorylation and SCF expression in LPS-treated animals."( Magnolol pretreatment prevents sepsis-induced intestinal dysmotility by maintaining functional interstitial cells of Cajal.
Miao, B; Wang, BE; Wang, H; Yang, T; Zhang, S; Zhou, D, 2013
)
2.55
"The magnolol-treated rats also exhibited decreased cerebral infarction volume and neuronal apoptosis and increased antiapoptosis-associated factor TGF-β1 expression."( Resuscitation from experimental traumatic brain injury by magnolol therapy.
Chio, CC; Kuo, JR; Lin, BS; Lin, KC; Wang, CC, 2013
)
1.12
"The magnolol-treated group had remarkably decreased activity levels of MMP-1, -9, and -13 compared to the corresponding levels in the vehicle-treated UVB-irradiated group."( Magnolol reduces UVB-induced photodamage by regulating matrix metalloproteinase activity.
Chae, S; Im, AR; Lee, MY; Song, JH, 2015
)
2.34
"Magnolol treatment correlated with up-regulation of transporter and ergosterol biosynthesis pathway genes, analyzed by real-time reverse transcription-polymerase chain reaction."( Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
Liang, S; Liao, K; Sun, LM; Wang, DY; Yu, PH, 2015
)
1.45
"Magnolol pretreatment decreased HS-induced cell injury through relief of this cell-cycle arrest."( Magnolol pretreatment attenuates heat stress-induced IEC-6 cell injury.
He, SS; Jiang, LS; Liu, FH; Lyu, A; Mei, C; Shi, YR; Xu, L; Yin, P; Yu, XH, 2016
)
2.6
"Magnolol pretreatment attenuates HS-induced injury in IEC-6 cells. "( Magnolol pretreatment attenuates heat stress-induced IEC-6 cell injury.
He, SS; Jiang, LS; Liu, FH; Lyu, A; Mei, C; Shi, YR; Xu, L; Yin, P; Yu, XH, 2016
)
3.32
"Magnolol treatment (60 microM) also caused a decrease in Ser((136)) phosphorylation of Bad (a proapoptotic protein), which is a downstream target of Akt."( Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
Lee, DH; Lee, YJ; Szczepanski, MJ, 2009
)
2.52
"Magnolol treatment decreased the protein levels of cyclins A and D1 and increased p21/Cip1, but not cyclins B and D3, cyclin-dependent kinase (CDK)2, CDK4, CDC25C, Weel, p27/Kip1, and p53."( Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1.
Chen, LC; Ho, YS; Lee, WS; Liang, YC; Liu, YC, 2009
)
2.52
"Magnolol treatment caused a dose-dependent inhibition of HER2 gene expression at the transcriptional level, potentially in part through suppression of NF-κB activation."( Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Cheng, YT; Chuang, TC; Fang, GS; Hsu, SC; Ou, CC; Shao, WS; Wang, V; Wu, K, 2011
)
2.53
"Magnolol pretreated groups (30, 60 μ g) before UVB treatments (30 mJ/cm2, 5 days/week) resulted in 27-55% reduction in tumor multiplicity as compared to control group in SKH-1 mice. "( Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
Chilampalli, C; Dwivedi, C; Fahmy, H; Guillermo, R; Hildreth, MB; Kaushik, RS; Young, A; Zeman, D; Zhang, X, 2011
)
2.2
"Magnolol pretreatments prevent UVB-induced skin cancer development by enhancing apoptosis, causing cell cycle arrest at G2/M phase, and affecting various signaling pathways. "( Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action.
Chilampalli, C; Dwivedi, C; Fahmy, H; Guillermo, R; Hildreth, MB; Kaushik, RS; Young, A; Zeman, D; Zhang, X, 2011
)
2.2
"Magnolol pretreatment significantly attenuated the severity of lung injury and inhibited the production of TNF-α and IL-1β in mice with ALI."( Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice.
Cheng, QS; Gu, ZP; Han, Y; Jiang, T; Ke, CK; Li, XF; Ni, YF; Wang, J; Wang, WP; Yan, XL; Zhang, ZP; Zhu, YF, 2012
)
1.42
"4 Magnolol treatment resulted in accumulation of cytosolic cytochrome c and activation of caspase-9 and downstream caspases (caspase-3 and -6)."( Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells.
Hsieh, MT; Hsu, SL; Tsai, TH; Yang, SE, 2003
)
1.19
"Magnolol-treated groups tolerated warm ischemia-reperfusion for 2 h and significantly less apoptotic cells were observed (198 +/- 22 vs 42.6 +/- 28)."( The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver.
Chen, CL; Chen, YS; Cheng, YF; Eng, HL; Goto, S; Hsieh, SW; Jawan, B; Lai, CY; Lan, KM; Lin, YC; Luk, HN; Pan, TL; Wang, CC, 2003
)
1.33
"Magnolol treatment blunted the TNFalpha levels in plasma and tissue."( Magnolol alters cytokine response after hemorrhagic shock and increases survival in subsequent intraabdominal sepsis in rats.
Lee, CH; Shih, HC; Wei, YH, 2003
)
2.48
"In magnolol-treated GK rats, fasting blood glucose and plasma insulin were significantly decreased, and the pancreatic islets also showed strong insulin antigen positivity."( Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Jang, DS; Jung, DH; Kim, CS; Kim, JS; Kim, YS; Lee, YM; Sohn, EJ, 2007
)
1.24
"Magnolol treatment strongly induced the expression of p21WAF1, but resulted in a decrease in cyclin-dependent kinases (CDKs) and cyclins involved in G1 progression."( Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Bae, SJ; Kim, BK; Kim, CH; Kim, DW; Kim, HM; Lee, SB; Lee, US; Moon, SK, 2007
)
1.39
"In magnolol-treated cells, the number and total area of cytoplasmic lipid droplets were reduced, suggesting a high utilization rate of cholesterol esters stored in lipid droplets."( Magnolol stimulates steroidogenesis in rat adrenal cells.
Chen, JJ; Chen, YL; Huang, YT; Lee, LJ; Wang, SM, 2000
)
2.26
"Magnolol treatment significantly inhibited Cu2+-induced LDL oxidation in cholesterol-fed rabbits and reduced atheroma formation [atheroma area ratio: 0.10 +/- 0.03 (HC-M) versus 0.33 +/- 0.07 (HC-C), p < 0.05] in thoracic aortas without lowering serum cholesterol. "( Magnolol, a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits.
Chen, YL; Chen, YT; Hong, CY; Lin, KF; Lin, SJ; Shiao, MS, 2001
)
3.2
"Treatment with magnolol (1) significantly inhibited osteoclast differentiation of RAW 264.7 macrophages and bone-resorbing activity of osteoclasts in the RANKL-induced system."( Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
Chen, TH; Chou, TC; Lu, SH, 2015
)
2.2
"Treatment with magnolol led to the inactivation of PKCδ/ERK and an increase in miR-124-3p expression, effectively inhibiting NF-κB-mediated progression of BC."( Unveiling nature's potential weapon: Magnolol's role in combating bladder cancer by upregulating the miR-124 and inactivating PKC-δ/ERK axis.
Chen, JH; Hsu, FT; Jeng, LB; Lee, SR; Liu, WL, 2023
)
1.52
"Treatment with magnolol alleviated depressive-like behaviors, reduced the levels of CORT, and improved the levels of BDNF protein, 5-HT, and NE compared with those in CORT-treated mice."( Antidepressant effects of magnolol in a mouse model of depression induced by chronic corticosterone injection.
Bai, Y; Dai, G; Jing, W; Ju, W; Song, L; Xu, M; Zhang, W; Zhu, L, 2018
)
1.12
"Pretreatment with magnolol resulted in the reduction of TPA-induced nuclear translocation of the nuclear factor-kappaB (NFkappaB) subunit and DNA binding by blocking the phosphorylation of IkappaBalpha and p65 and subsequent degradation of IkappaBalpha."( Inhibitory effect of magnolol on TPA-induced skin inflammation and tumor promotion in mice.
Cheng, AC; Kuo, DH; Lai, YS; Lo, CY; Pan, MH; Wu, H, 2010
)
1
"Post-treatment with magnolol significantly attenuated the deleterious haemodynamic changes (e.g., hypotension and bradycardia) caused by LPS."( Beneficial effects of magnolol in a rodent model of endotoxin shock.
Cheng, PY; Ke, TH; Kung, CW; Peng, YJ; Tsai, YC; Wang, JJ; Yen, MH, 2010
)
0.99
"Pretreatment with magnolol prior to antimycin A exposure significantly reduced antimycin A-induced osteoblast dysfunction by preventing MMP dissipation, ATP loss, and CREB inactivation."( Magnolol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity through activation of mitochondrial function.
Choi, EM, 2012
)
2.15
"Treatment with magnolol significantly prevented the decrease of neurofibrils in the CA1, when it was administered in 2-month-olds."( Neurotrophic effect of magnolol in the hippocampal CA1 region of senescence-accelerated mice (SAMP1).
Akagi, M; Akagi, R; Fukuishi, N; Fukuyama, Y; Matsui, N; Nakade, K; Nakashima, H; Shirono, A; Tada, T; Ushio, Y; Yasui, Y; Zhai, H, 2005
)
0.98
"Pre-treatment of magnolol blocked TNF-alpha-induced NF-kappaB activation in different cell types as evidenced by EMSA."( Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Cheung, HY; Fong, WF; Shen, XL; Tse, AK; Wan, CK; Yang, M; Zhu, GY, 2007
)
2.11
"Treatment with magnolol (10 and 100 microM) significantly reduced the KCN-induced LDH release in a concentration-dependent manner."( Magnolol protects cortical neuronal cells from chemical hypoxia in rats.
Hseih, MT; Huang, HM; Kuo, JS; Lee, MM; Yeh, FT, 1998
)
2.08
"Pretreatment with magnolol (10(-7) and 10(-6) g/kg, intravenous infusion) significantly enhanced the recovery of systolic wall thickening fraction (98 +/- 1 and 99 +/- 1% of baseline WThF, respectively) 60 minutes after CAR."( Intravenous pretreatment with magnolol protects myocardium against stunning.
Chih, CL; Hong, CY; Hsieh, YH; Huang, CH; Lai, ST; Tsai, SK; Weng, ZC, 2000
)
0.92

Toxicity

ExcerptReferenceRelevance
" In this regard, the toxic effect of Aβ on a cultured Aβ-sensitive neuronal cell line was used as a primary screening tool for potential anti-Alzheimer's therapeutic agents."( Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells.
Baum, L; Chow, AH; Ho, YP; Hoi, CP, 2010
)
0.63
" dealbata and its active compounds have selective antimicrobial effects against drug-resistant fungal and Gram (-) bacteria and exert minimal toxic effects on human PMBC."( Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds.
Alonso-Castro, AJ; Domínguez, F; Garcia-Carranca, A; Gonzalez-Espindola, LA; Gonzalez-Martinez, Mdel R; Jacobo-Salcedo, Mdel R, 2011
)
0.37

Pharmacokinetics

The levels of aloe-emodin, rhein, emodin,. chrysophanol, honokiol, magnolol, hesperidin, and naringin in rat serum were quantified using a liquid chromatography tandem mass spectrometry (LC-MS/MS) method for pharmacokinetic study.

ExcerptReferenceRelevance
"SAP can significantly impact the absorption of DCQD components in rats and their pharmacokinetic parameters."( Effect of severe acute pancreatitis on pharmacokinetics of Da-Cheng-Qi Decoction components.
Chen, GY; Gong, HL; Huang, X; Liang, MZ; Tang, WF; Xia, Q; Xiang, J; Yu, Q, 2009
)
0.35
"A simple LC-MS/MS method was developed for determination and pharmacokinetic study of magnolol in rat blood."( A simple LC-MS/MS method for determination of magnolol in rat blood and its application in a pharmacokinetic study.
Di, W; Li, H; Wen, XS, 2012
)
0.86
" The levels of aloe-emodin, rhein, emodin, chrysophanol, honokiol, magnolol, hesperidin, and naringin in rat serum were quantified using a liquid chromatography tandem mass spectrometry (LC-MS/MS) method for pharmacokinetic study."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.62
"The area under the curve (AUC), mean retention time (MRT), the peak concentration (C(max)) of aloe-emodin, rhein, emodin, and chrysophanol in the DCQD group were significantly different compared with the Dahuang group (P <0."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.38
"The compatibility in Chinese medicine could affect the drug's pharmacokinetics in DCQD, which proves that the prescription compatibility principle of Chinese medicine formulations has its own pharmacokinetic basis."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.38
" Here we determine the pharmacokinetic characteristics of the four most abundant compounds in DCQD using a rat model of severe acute pancreatitis."( Pharmacokinetic and pharmacodynamic studies of four major phytochemical components of Da-Cheng-Qi decoction to treat acute pancreatitis.
Chen, G; Gong, H; Tang, W; Wang, J; Xiang, J; Zhao, J, 2013
)
0.39
" This study aims to determine the isomers in rat plasma and evaluate their pharmacokinetic pattern after administration emulsion."( UPLC-MS/MS-ESI assay for simultaneous determination of magnolol and honokiol in rat plasma: application to pharmacokinetic study after administration emulsion of the isomer.
Li, N; Li, W; Sheng, YL; Shi, CH; Xu, HY; Xu, JH; Zhang, XR; Zhao, YQ, 2014
)
0.65
" Compared with the HP group, Tmax (time to reach peak drug concentration in plasma) and AUC(0-τ) significantly increased in the ZZHPD and HP-ZZ groups."( Comparative pharmacokinetics and brain distribution of magnolol and honokiol after oral administration of Magnolia officinalis cortex extract and its compatibility with other herbal medicines in Zhi-Zi-Hou-Po Decoction to rats.
Feng, F; Liu, Y; Shi, Q; Wang, D; Yang, G, 2016
)
0.68
" In order to make good and rational use of this formula in the future, this paper presents the first attempt to track the pharmacokinetic features of MZRW in rat using rapid and sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS)."( Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan.
Bian, ZX; Han, QB; Ho, HM; Hu, DD; Huang, T; Li, YH; Lin, CY; Lin, SH; Mi, H; Tan, HS; Xu, HX; Zhang, M; Zhao, L; Zhong, LL, 2015
)
0.42
"To conduct multiple-reaction monitoring(MRM) quantitative analysis with high-performance liquid chromatography coupled with mass spectrometry method, establish the quantification method of magnolol and honokiol in blood sample under negative ion mode with ibuprofen as internal standard, investigate the pharmacokinetic process of lignans constituents after oral administration of Weichang'an pill(WCA) at different doses, and provide theoretical basis to further reveal the material basis of WCA's anti-diarrhea effect."( [Pharmacokinetics of magnolol and honokiol in Weichang'an pill].
Chen, H; Chen, YL; Gao, WY; Jin, ZX; Wang, L; Wang, SP; Zhang, JZ, 2016
)
0.94
" The pharmacokinetics of three glycosides (magnoloside A, magnoloside B, and syringin) and two lignans (honokiol and magnolol) in both normal and functional dyspepsia rats were firstly investigated by ultra-performance liquid chromatography-triple quadrupole mass spectrometry method and the influences of the coexisting compounds on the pharmacokinetic parameters of honokiol and magnolol were also studied."( Pharmacokinetics and metabolites of glycosides and lignans of the stem bark of Magnolia officinalis in functional dyspepsia and normal rats using liquid chromatography-tandem mass spectrometry.
Hou, L; Kang, L; Li, H; Nan, T; Rong, P; Sun, J; Wang, W; Yang, B; Yang, W; Zhang, J, 2022
)
0.93

Compound-Compound Interactions

ExcerptReferenceRelevance
"A novel surface plasmon resonance-based P-gp ligand screening system (SPR-PLSS) combined with lentiviral particle (LVP) stabilization strategy was constructed to screen out potential P-gp inhibitors from natural products."( Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands.
Cai, Y; Cao, Y; Chai, Y; Chen, L; Chen, X; Hong, Z; Liu, Y; Shi, Y; Wang, D; Zhu, Z, 2021
)
0.62

Bioavailability

Magnolol-loaded amorphous solid dispersion with PVP has demonstrated enhanced bioavailability of magnolol in rabbits. Results suggest that the magnol might be responsible for the therapeutic effect of Saiboku-To, indicating practical bioavailability in the responders.

ExcerptReferenceRelevance
" These results suggest that the magnolol might be responsible for the therapeutic effect of Saiboku-To, indicating practical bioavailability in the responders."( Impact of free magnolol excretions in asthmatic patients who responded well to saiboku-to, a Chinese herbal medicine.
Homma, M; Itoh, H; Kobayashi, H; Niitsuma, T; Oka, K; Takahashi, N; Yamamoto, S, 1993
)
0.92
" To understand the pharmacokinetics and bioavailability of M, Sprague-Dawley rats were intravenously injected with a bolus of M (20 mg/kg) and orally given a single dose and seven doses of M (50 mg/kg)."( Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats.
Chen, YC; Hou, YC; Lee Chao, PD; Lin, SP; Tsai, SY, 2011
)
0.61
" Subsequently, the bioavailability of magnolol pure compound, its physical mixture and solid dispersion were compared in rabbits."( Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone.
Hou, YC; Liao, TY; Lin, SP; Tsai, SY, 2014
)
0.95
"Magnolol-loaded amorphous solid dispersion with PVP has demonstrated enhanced bioavailability of magnolol in rabbits."( Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone.
Hou, YC; Liao, TY; Lin, SP; Tsai, SY, 2014
)
2.13
" The absolute bioavailability of magnolol and honokiol is 17."( UPLC-MS/MS-ESI assay for simultaneous determination of magnolol and honokiol in rat plasma: application to pharmacokinetic study after administration emulsion of the isomer.
Li, N; Li, W; Sheng, YL; Shi, CH; Xu, HY; Xu, JH; Zhang, XR; Zhao, YQ, 2014
)
0.93
" There was little change in the HP-ZS group in comparison with the HP group, which indicated that ZZ promotes absorption extent and defers the absorption rate of MN."( Comparative pharmacokinetics and brain distribution of magnolol and honokiol after oral administration of Magnolia officinalis cortex extract and its compatibility with other herbal medicines in Zhi-Zi-Hou-Po Decoction to rats.
Feng, F; Liu, Y; Shi, Q; Wang, D; Yang, G, 2016
)
0.68
" The definite bioavailability of honokiol (HO) and magnolol (MA) in processed MO (PMO) and the effect of chemical profiling change on the pharmacokinetics of HO and MA are always a greater challenge compared with those of MO."( Effect of Chemical Profiling Change of Processed Magnolia officinalis on the Pharmacokinetic Profiling of Honokiol and Magnolol in Rats.
Hu, H; Hua, W; Wang, Z; You, Y; Zou, L, 2016
)
0.89
" The influence of PVPP on MPC's flowability, dissolution and oral bioavailability was investigated."( [Solidification of magnolol phospholipid complex with polyvingypyrrolidone].
Dai, YH; Ju, JM; Wang, M; Zhang, ZH, 2016
)
0.76
"83-fold increase in relative oral bioavailability compared with raw MAG."( Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61.
Ding, P; Ju, J; Liang, G; Liu, S; Shen, H; Wang, L, 2018
)
0.75
"The mixed micelles containing pluronic F127 and L61 as drug delivery system provided a well strategy for resolving the poor solubility and bioavailability problems of MAG."( Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61.
Ding, P; Ju, J; Liang, G; Liu, S; Shen, H; Wang, L, 2018
)
0.75
" More research is needed to improve the bioavailability of magnolol and honokiol and perform experiments to examine the therapeutic potential of magnolol and honokiol."( The Neuropharmacological Effects of Magnolol and Honokiol: A Review of Signal Pathways and Molecular Mechanisms.
Cao, Y; Dai, X; Li, X; Liang, Y; Liu, K; Lu, J; Wang, X; Xie, L; Zhang, X, 2023
)
1.43
"This article aimed to design a new type of supersaturated solid dispersion (NS-SD) loaded with Magnolol (Mag) to raise the oral bioavailability in rats."( Preparation and Evaluation of Novel Supersaturated Solid Dispersion of Magnolol : Theme: Advancements in Amorphous Solid Dispersions to Improve Bioavailability.
Deng, W; Gao, P; Ji, D; Mu, C; Ning, J; Sun, H; Yang, X; Zhang, X; Zhao, J, 2022
)
1.17

Dosage Studied

Magnolol under low and moderate dosage possesses the ability to protect heart from ischemic/reperfusion injury, reduces atherosclerotic change, protects endothelial cell against apoptosis and inhibits neutrophil-endothelial adhesion. More importantly, intratracheal delivery of these magnolol-loaded microparticles significantly reduced the lung inflammatory responses at low dosage.

ExcerptRelevanceReference
" Magnolol under low and moderate dosage possesses the ability to protect heart from ischemic/reperfusion injury, reduces atherosclerotic change, protects endothelial cell against apoptosis and inhibits neutrophil-endothelial adhesion."( Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.
Ho, JH; Hong, CY, 2012
)
1.58
" The blood samples were collected before dosing and subsequently at 10, 15, 20, 30, 45 min, 1, 2, 4, 8, and 12 h following gavage."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.38
" More importantly, intratracheal delivery of these magnolol-loaded microparticles significantly reduced the lung inflammatory responses at low dosage of magnolol (0."( Protective effect of magnolol-loaded polyketal microparticles on lipopolysaccharide-induced acute lung injury in rats.
Chou, CL; Chou, TC; Kao, CY; Liu, LC; Tsai, T, 2016
)
1.01
" In addition, Mag-NS-SD was prepared by adding Monoglyceride (MG) and Lecithin High Potency (LHP) into the Mag-S-SD (Mag:PS-630 = 1:3), so as to reduce the dosage of carrier and improve the release rate."( Preparation and Evaluation of Novel Supersaturated Solid Dispersion of Magnolol : Theme: Advancements in Amorphous Solid Dispersions to Improve Bioavailability.
Deng, W; Gao, P; Ji, D; Mu, C; Ning, J; Sun, H; Yang, X; Zhang, X; Zhao, J, 2022
)
0.95
" The optimal processing parameters of GMOC were ginger juice dosage of 8%, moistening time of 120 min, and processing at 100 ℃ for 7 min."( [Processing Magnoliae Officinalis Cortex with ginger juice: process optimization based on AHP-CRITIC weighting method and composition changes after processing].
Fan, XC; Lu, TL; Mao, CQ; Qi, YF; Su, YA; Wang, SC; Zhang, KW, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (3 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care3

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Attitude Oatmeal Sensitive Natural Care Hand Cream - Unscented -- 2.5 fl ozAttitudeBeauty & Personal Carecaprylyl glycol, cetearyl alcohol, glyceryl stearate, glycerin, honokiol, magnolol2024-11-29 10:47:42
BioRepublic Skincare Firming Facelift Magic Moss Cream -- 1 fl ozBioRepublic SkincareBeauty & Personal Carebutylene glycol, citric acid, ascorbyl palmitate, betaine, carbomer, chlorphenesin, citric acid, cyclopentasiloxane, panthenol, hydroxyphenyl propamidobenzoic acid, glycerin, dimethicone, magnolol, glyceryl laurate, o-cymen-5-ol, phenoxyethanol, propylene glycol, triethanolamine2024-11-29 10:47:42
BioRepublic Skincare Firming Facelift Magic Moss Mask -- 0.85 fl ozBioRepublic SkincareBeauty & Personal Carebutylene glycol, 1,4-butanediol, ascorbyl palmitate, benzoic acid, cetearyl alcohol, cetyl palmitate, chlorphenesin, panthenol, hydroxyphenyl propamidobenzoic acid, beta-glucan, ethylhexylglycerin, glyceryl stearate, glycerin, linalool, magnolol, o-cymen-5-ol, phenoxyethanol, propylene glycol2024-11-29 10:47:42

Drug Classes (1)

ClassDescription
biphenylsBenzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (33)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency28.18380.177814.390939.8107AID2147
Chain A, Ferritin light chainEquus caballus (horse)Potency19.58355.623417.292931.6228AID485281
glp-1 receptor, partialHomo sapiens (human)Potency11.22020.01846.806014.1254AID624417
TDP1 proteinHomo sapiens (human)Potency17.58860.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency0.56230.180013.557439.8107AID1468
thioredoxin glutathione reductaseSchistosoma mansoniPotency56.23410.100022.9075100.0000AID485364
Smad3Homo sapiens (human)Potency35.48130.00527.809829.0929AID588855
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency11.22020.28189.721235.4813AID2326
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency15.84890.035520.977089.1251AID504332
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency31.62280.036619.637650.1187AID2100
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency31.62280.001815.663839.8107AID894
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency89.12513.548119.542744.6684AID743266
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency22.98330.00798.23321,122.0200AID2546
gemininHomo sapiens (human)Potency9.20000.004611.374133.4983AID624296
VprHuman immunodeficiency virus 1Potency63.09571.584919.626463.0957AID651644
neuropeptide S receptor isoform AHomo sapiens (human)Potency12.58930.015812.3113615.5000AID1461
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency31.62280.316212.765731.6228AID881
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency31.62280.00638.235039.8107AID881
TAR DNA-binding protein 43Homo sapiens (human)Potency35.48131.778316.208135.4813AID652104
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency50.11873.981146.7448112.2020AID720708
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TPA: protein transporter TIM10Saccharomyces cerevisiae S288CIC50 (µMol)68.30000.580026.547675.8000AID493003
high affinity choline transporter 1 isoform aHomo sapiens (human)IC50 (µMol)2.29520.00036.210228.8403AID504840; AID588401
Cannabinoid receptor 1Homo sapiens (human)Ki2.57500.00010.50779.6000AID1799559; AID731350
Cannabinoid receptor 2 Homo sapiens (human)Ki1.72000.00000.415610.0000AID1799559; AID731349
G-protein coupled bile acid receptor 1Homo sapiens (human)Ki1.44000.00141.59915.6100AID731349
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Retinoic acid receptor RXR-alphaHomo sapiens (human)Kd1.67001.67001.67001.6700AID977611
Chain A, Peroxisome proliferator-activated receptor gammaHomo sapiens (human)Kd1.67001.67001.67001.6700AID977611
Aldehyde dehydrogenase, mitochondrialHomo sapiens (human)EC50 (µMol)57.90004.30004.30004.3000AID1762956
Cytochrome P450 3A4Homo sapiens (human)EC50 (µMol)36.80000.00010.23283.2000AID611249
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)EC50 (µMol)20.80000.00112.000910.0000AID1891770; AID611249
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)EC50 (µMol)4.80000.00141.957810.0000AID1891770
Cannabinoid receptor 1Homo sapiens (human)EC50 (µMol)18.30000.00010.12752.2400AID731338
Cannabinoid receptor 2 Homo sapiens (human)EC50 (µMol)3.28000.00030.15173.2800AID731339
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)EC50 (µMol)20.80000.00141.776810.0000AID1891770; AID611249
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (127)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
carbohydrate metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
alcohol metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
ethanol catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of dopamine biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of serotonin biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
post-embryonic developmentGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
adult behaviorGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
positive regulation of acute inflammatory response to antigenic stimulusCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
spermatogenesisCannabinoid receptor 1Homo sapiens (human)
axonal fasciculationCannabinoid receptor 1Homo sapiens (human)
response to nutrientCannabinoid receptor 1Homo sapiens (human)
memoryCannabinoid receptor 1Homo sapiens (human)
positive regulation of neuron projection developmentCannabinoid receptor 1Homo sapiens (human)
negative regulation of serotonin secretionCannabinoid receptor 1Homo sapiens (human)
positive regulation of fever generationCannabinoid receptor 1Homo sapiens (human)
negative regulation of fatty acid beta-oxidationCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, GABAergicCannabinoid receptor 1Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 1Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 1Homo sapiens (human)
negative regulation of dopamine secretionCannabinoid receptor 1Homo sapiens (human)
response to nicotineCannabinoid receptor 1Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 1Homo sapiens (human)
response to cocaineCannabinoid receptor 1Homo sapiens (human)
glucose homeostasisCannabinoid receptor 1Homo sapiens (human)
positive regulation of apoptotic processCannabinoid receptor 1Homo sapiens (human)
response to ethanolCannabinoid receptor 1Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 1Homo sapiens (human)
negative regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
positive regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
regulation of insulin secretionCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicCannabinoid receptor 1Homo sapiens (human)
maternal process involved in female pregnancyCannabinoid receptor 1Homo sapiens (human)
regulation of feeding behaviorCannabinoid receptor 1Homo sapiens (human)
regulation of penile erectionCannabinoid receptor 1Homo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidCannabinoid receptor 1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationCannabinoid receptor 1Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 1Homo sapiens (human)
response to amphetamineCannabinoid receptor 2 Homo sapiens (human)
inflammatory responseCannabinoid receptor 2 Homo sapiens (human)
immune responseCannabinoid receptor 2 Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 2 Homo sapiens (human)
leukocyte chemotaxisCannabinoid receptor 2 Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicCannabinoid receptor 2 Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 2 Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 2 Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 2 Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 2 Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chemical synaptic transmissionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inner ear receptor cell developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
innervationGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cochlea developmentGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
regulation of membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
cell surface bile acid receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeG-protein coupled bile acid receptor 1Homo sapiens (human)
cellular response to bile acidG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of cholangiocyte proliferationG-protein coupled bile acid receptor 1Homo sapiens (human)
regulation of bicellular tight junction assemblyG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (60)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde dehydrogenase [NAD(P)+] activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
phenylacetaldehyde dehydrogenase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
electron transfer activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
nitroglycerin reductase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
NAD bindingAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
carboxylesterase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
protein bindingGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 1Homo sapiens (human)
identical protein bindingCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 2 Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 2 Homo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
protein bindingG-protein coupled bile acid receptor 1Homo sapiens (human)
bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (44)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
mitochondrionAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
mitochondrial matrixAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
extracellular exosomeAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
axonGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
mitochondrial outer membraneCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
actin cytoskeletonCannabinoid receptor 1Homo sapiens (human)
growth coneCannabinoid receptor 1Homo sapiens (human)
presynaptic membraneCannabinoid receptor 1Homo sapiens (human)
membrane raftCannabinoid receptor 1Homo sapiens (human)
glutamatergic synapseCannabinoid receptor 1Homo sapiens (human)
GABA-ergic synapseCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
cytoplasmCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
dendriteCannabinoid receptor 2 Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneCannabinoid receptor 2 Homo sapiens (human)
perikaryonCannabinoid receptor 2 Homo sapiens (human)
endoplasmic reticulumCannabinoid receptor 2 Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
cytoplasmCannabinoid receptor 2 Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
extracellular exosomeGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
receptor complexG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (229)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1190403Inhibition of MMP9 activity in RANKL-induced mouse RAW264.7 cells at 20 uM after 24 hrs by immunofluorescence staining in presence of tin protoporphyrin 9 (SnPP)2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID164714Compound was tested for minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27852001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID1727642Antiproliferative activity against human A549 cells expressing wild type EGFR assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID1762952Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in collagen synthesis by measuring reduction in type1 collagen protein expression measured after 24 hrs by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1773502Hemolytic activity in sheep RBC assessed as hemolysis incubated for 1 hr
AID337442Cytotoxicity against human Raji cells assessed as cell viability at 1 molar ratio
AID1396633Binding affinity to recombinant human N-terminal GSt-tagged TNKS1 (1000 to 1328 residues) expressed in baculovirus infected Sf9 cells by surface plasmon resonance analysis2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors.
AID1742337Antiproliferative activity against human LO2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy.
AID611429Modulation of GABA Aalpha1beta2 receptor expressed in Xenopus laevis oocytes assessed as potentiation of GABA-induced chloride current at holding potential -70 mV at 30 uM by two-microelectrode voltage clamp technique relative to GABA2011Journal of medicinal chemistry, Aug-11, Volume: 54, Issue:15
Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.
AID1361276Antiproliferative activity against human NCI-H1650 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID1762964Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in collagen synthesis by measuring reduction in type3 collagen protein expression measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by western2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1666900Antiproliferative activity against human H460 cells assessed as inhibition of cell viability incubated for 24 hrs by CCK-8 assay2020Bioorganic & medicinal chemistry, 03-15, Volume: 28, Issue:6
CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis.
AID738971Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for Hepatitis B virus infected in human HepG2.2.15 cells by HBsAg secretion inhibition assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-hepatitis B virus lignans from the root of Streblus asper.
AID1265388Antifungal activity against Candida albicans SC5314 assessed as inhibition of yeast to hyphae conversion after 4 hrs by microscopic analysis2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Bioactive ent-Pimarane and ent-Abietane Diterpenoids from the Whole Plants of Chloranthus henryi.
AID297147Inhibition of SARS virus-induced cytopathogenicity in Vero E6 cells at 3.3 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID1762957Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as inhibition of cell viability measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by MTT assay2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID611249Modulation of GABA Aalpha1beta2 receptor expressed in Xenopus laevis oocytes assessed as potentiation of GABA-induced chloride current at holding potential -70 mV by two-microelectrode voltage clamp technique2011Journal of medicinal chemistry, Aug-11, Volume: 54, Issue:15
Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.
AID337437Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 1 molar ratio after 48 hrs relative to TPA
AID1190401Inhibition of MMP9 activity in RANKL-induced mouse RAW264.7 cells at 20 uM after 24 hrs by immunofluorescence staining2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1762945Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as inhibition of cell viability measured after 24 hrs by MTT assay2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID611340Modulation of GABA Aalpha1beta2 receptor expressed in Xenopus laevis oocytes assessed as potentiation of GABA-induced chloride current at holding potential -70 mV by two-microelectrode voltage clamp technique relative to GABA2011Journal of medicinal chemistry, Aug-11, Volume: 54, Issue:15
Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.
AID731333Ratio of EC50 for recombinant human CB1 receptor expressed in CHO cells to recombinant human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation2013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID337438Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio
AID1190389Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 5 to 20 uM after 24 hrs by MTT assay2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1181043Inhibition of LPS-induced NO production in mouse RAW264.7 cells after 24 hrs by Griess reagent based assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
2-Phenoxychromones and prenylflavonoids from Epimedium koreanum and their inhibitory effects on LPS-induced nitric oxide and interleukin-1β production.
AID738967Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for Hepatitis B virus infected human HepG2.2.15 cells by DNA replication assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-hepatitis B virus lignans from the root of Streblus asper.
AID613707Neurotrophic activity in isolated embryonic mouse brain Hippocampal neurons assessed as induction of neurite outgrowth at 1 uM after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID1773499Antibacterial activity against Stenotrophomonas maltophilia assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID205807Compound was tested for minimum inhibitory concentration against Staphylococcus aureus ATCC 259232001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID1190398Antiosteoclast activity in mouse RAW264.7 cells assessed as reduction of RANKL-induced osteoclasts differentiation by measuring TRAP positive multinucleated cells after 5 days in presence of tin protoporphyrin 9 (SnPP)2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID292086Cytotoxicity against Vero cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID1762954Agonist activity at ALDH2 in cardiac fibroblasts (unknown origin) measured after 24 hrs by ELISA2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1762955Effect on ALDH2 expression in cardiac fibroblasts (unknown origin) at 5 to 20 uM measured after 24 hrs by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID292083Antiviral activity against HIV1 in human PBM cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID613709Neurotrophic activity in isolated embryonic mouse embryonic Cortical neurons assessed as induction of neurite outgrowth at 0.01 uM after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID1190391Inhibition of RANKL-stimulated JNK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1742333Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy.
AID1727647Metabolic stability in human liver microsomes assessed as half life2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID1762953Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in collagen synthesis by measuring reduction in type3 collagen protein expression measured after 24 hrs by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID648738Antiproliferative activity against human HL60 cells after 48 hrs by sulforhodamine B assay2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID1762971Binding affinity to ALDH2 (unknown origin) by surface plasmon resonance analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1727641Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID1762947Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as inhibition of cell proliferation measured after 24 hrs by EdU incorporation based assay2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID422521Antioxidant activity assessed as DPPH free radical scavenging activity2009Journal of natural products, Jan, Volume: 72, Issue:1
Phenolic constituents from the stem bark of Magnolia officinalis.
AID738969Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion after 12 days by ELISA2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-hepatitis B virus lignans from the root of Streblus asper.
AID422520Inhibition of NADPH oxidase-mediated ROS production in LPS-stimulated mouse BV2 cells after 20 mins by flow cytometry2009Journal of natural products, Jan, Volume: 72, Issue:1
Phenolic constituents from the stem bark of Magnolia officinalis.
AID123051Compound was tested for minimum inhibitory concentration against Micrococcus luteus ATCC 93412001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID1361275Antiproliferative activity against human SPC-A1 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID599127Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID1762948Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in CDK4 protein expression measured after 24 hrs by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID648731Antibacterial activity against methicillin-resistant Staphylococcus aureus 15187 after 24 hrs by micro dilution method2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID1190390Antiosteoclast activity in mouse RAW264.7 cells assessed as reduction of RANKL-induced osteoclasts differentiation by measuring TRAP positive multinucleated cells after 5 days2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1405807Agonist activity at human MT2 receptor expressed in HEK293 cells at 1 mM after 24 hrs by Fluo-8 dye-based calcium assay relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
AID550837Antibacterial activity against Micrococcus luteus ATCC 9341 assessed as inhibition of visible growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Ring A-seco triterpenoids with antibacterial activity from Dysoxylum hainanense.
AID1762960Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in cyclinD1 protein expression measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID648739Antiproliferative activity against human PC3 cells after 48 hrs by sulforhodamine B assay2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID731349Displacement of [3H]CP55,940 from recombinant human CB2 receptor expressed in CHO cells after 2 hrs by liquid scintillation counting2013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID1361273Antiproliferative activity against human H460 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID297150Cytotoxicity against Vero E6 cells by MTT assay2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID731336Inhibition of FAAH in rat brain microsome using pyrenylbutanamide as substrate after 60 mins by HPLC analysis2013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID613712Neurotrophic activity in isolated embryonic mouse embryonic Cortical neurons assessed as induction of neurite outgrowth after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID1727643Antiproliferative activity against human SPCA1 cells expressing wild type EGFR assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID599122Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID337439Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio
AID1727648Metabolic stability in human liver microsomes assessed as intrinsic clearance per gram protein2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID599121Antibacterial activity against Micrococcus pyogenes clinical isolate after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID1762951Effect on Bcl2 protein expression in cardiac fibroblasts (unknown origin) at 5 to 20 uM incubated for 24 hrs by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1396631Binding affinity to recombinant human N-terminal His-tagged TNKS2 (Ser959 to Gly1166 residues) expressed in Escherichia coli by surface plasmon resonance analysis2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors.
AID613708Neurotrophic activity in isolated embryonic mouse brain Hippocampal neurons assessed as induction of neurite outgrowth after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID1727645Antiproliferative activity against human NCI-H441 cells expressing EGFR mutant assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID1190392Inhibition of RANKL-stimulated ERK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1742334Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy.
AID1190402Inhibition of NFATc1 expression in RANKL-induced mouse RAW264.7 cells at 20 uM after 24 hrs by immunofluorescence staining in presence of tin protoporphyrin 9 (SnPP)2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID731345Agonist activity at recombinant human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation at 100 uM after 5 mins by cAMP-competition binding assay relative to CP55,9402013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID1773500Antibacterial activity against Salmonella enterica 349812 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID337434Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 500 molar ratio after 48 hrs relative to TPA
AID265950Cytotoxicity against human PBM cells2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Facile purification of honokiol and its antiviral and cytotoxic properties.
AID377347Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by broth microdilution test2005Journal of natural products, Feb, Volume: 68, Issue:2
Lignans and their degraded derivatives from Sarcostemma acidum.
AID1727639Antiproliferative activity against human HCC827 cells assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID311630Cytotoxicity against human HeLa cells by MTT assay2007Journal of natural products, Oct, Volume: 70, Issue:10
Cytotoxic lignans from the stem bark of Magnolia officinalis.
AID599129Antibacterial activity against Pseudomonas aeruginosa ATCC 14502 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID648733Antibacterial activity against Staphylococcus aureus ATCC 29213 treated for 24 hrs followed by compound treated at 2 to 16 times MIC measured after 24 hrs by micro dilution method2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID738973Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion after 12 days by ELISA2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-hepatitis B virus lignans from the root of Streblus asper.
AID292081Antiproliferative activity against mouse SVR cells at 10 ug/mL after 72 hrs2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID666151Inhibition of PA endonuclease at 1 uM2011PloS one, , Volume: 6, Issue:5
Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.
AID247905Cytotoxicity of compound against human liver tumor cell line (Hep-G2) was determined2005Bioorganic & medicinal chemistry letters, Jan-03, Volume: 15, Issue:1
Cytotoxic neolignans: an SAR study.
AID297149Antiviral activity against SARS coronavirus in Vero E6 cells assessed as inhibition of viral replication by ELISA2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID399386Anxiolytic activity in ddY mouse assessed as time spent in open-sided arms at 0.49 mg/kg, po administered once daily for 7 days by elevated plus-maze test1998Journal of natural products, Jan, Volume: 61, Issue:1
Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine.
AID1666899Inhibition of colony formation in human A549 cells at 20 uM incubated for 48 hrs and measured after 10 days culturing in normal media by Giemsa staining based inverted microscopy2020Bioorganic & medicinal chemistry, 03-15, Volume: 28, Issue:6
CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis.
AID1666895Antiproliferative activity against human A549 cells assessed as inhibition of cell viability incubated for 24 hrs by CCK-8 assay2020Bioorganic & medicinal chemistry, 03-15, Volume: 28, Issue:6
CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis.
AID337433Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio after 48 hrs relative to TPA
AID1762962Effect on Bax protein expression in cardiac fibroblasts (unknown origin) measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID337436Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 10 molar ratio after 48 hrs relative to TPA
AID1361272Antiproliferative activity against human NCI-H1975 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID779150Inhibition of Wnt/beta-catenin signaling pathway in human HEK293 cells at 20 uM after 24 hrs by dual luciferase reporter gene assay relative to vehicle-treated control2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
AID1361280Apparent aqueous solubility of the compound by HPLC analysis2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID731350Displacement of [3H]CP55,940 from recombinant human CB1 receptor expressed in CHO cells after 2 hrs by liquid scintillation counting2013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID1773498Antibacterial activity against Escherichia coli ATCC25922 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID311632Cytotoxicity against human K562 cells by MTT assay2007Journal of natural products, Oct, Volume: 70, Issue:10
Cytotoxic lignans from the stem bark of Magnolia officinalis.
AID337440Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio
AID1361278Antiproliferative activity against human H441 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID1361271Antiproliferative activity against human HCC827 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID292085Cytotoxicity against human CEM cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID1762949Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in cyclinD1 protein expression measured after 24 hrs by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1396638Binding affinity to BRD9 (unknown origin) by surface plasmon resonance analysis2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors.
AID1405914Drug level in Sprague-Dawley rat urine treated with Magnolol-4'-O-beta-D-glucopyranoside at 100 mg/kg, po by UPLC-IT-TOF-MS analysis2018European journal of medicinal chemistry, Aug-05, Volume: 156Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
AID311631Cytotoxicity against human A549 cells by MTT assay2007Journal of natural products, Oct, Volume: 70, Issue:10
Cytotoxic lignans from the stem bark of Magnolia officinalis.
AID1440411Antifungal activity against Cryptococcus neoformans KCTC 7224 clinical isolates after 7 days by two fold serial dilution method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Tackling Fungal Resistance by Biofilm Inhibitors.
AID731335Inhibition of MAGL in rat brain microsome using pyrenylbutanamide as substrate after 60 mins by HPLC analysis2013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID738970Selectivity index, ratio of CC50 for human HepG2(2.2.15) cells to IC50 for Hepatitis B virus infected in human HepG2.2.15 cells assessed as HBeAg secretion inhibition assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-hepatitis B virus lignans from the root of Streblus asper.
AID599124Antibacterial activity against Micrococcus luteus ATCC 9341 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID731346Agonist activity at recombinant human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation at 100 uM after 5 mins by cAMP-competition binding assay relative to CP55,9402013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID1762946Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as inhibition of cell viability at 20 uM measured for 120 hrs by MTT assay2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID550839Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of visible growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Ring A-seco triterpenoids with antibacterial activity from Dysoxylum hainanense.
AID613710Neurotrophic activity in isolated embryonic mouse embryonic Cortical neurons assessed as induction of neurite outgrowth at 0.1 uM after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID599131Antibacterial activity against Alcaligenes faecalis ATCC 8750 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID341726Antibacterial activity against Micrococcus luteus ATCC 9341 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antimicrobial diterpenes from Trigonostemon chinensis.
AID1405849Retention time of the compound by UPLC-IT-TOF-MS analysis2018European journal of medicinal chemistry, Aug-05, Volume: 156Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
AID550840Antibacterial activity against Shigella flexneri ATCC 12022 assessed as inhibition of visible growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Ring A-seco triterpenoids with antibacterial activity from Dysoxylum hainanense.
AID550836Antibacterial activity against Staphylococcus epidermidis ATCC 12228 assessed as inhibition of visible growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Ring A-seco triterpenoids with antibacterial activity from Dysoxylum hainanense.
AID550835Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of visible growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Ring A-seco triterpenoids with antibacterial activity from Dysoxylum hainanense.
AID1847354Inhibition of NDM-1 (unknown origin) expressed in Escherichia coli Zc-YN32021European journal of medicinal chemistry, Nov-05, Volume: 223Recent research and development of NDM-1 inhibitors.
AID648735Antibacterial activity against vancomycin-resistant Enterococcus treated for 24 hrs followed by compound treated at 2 to 16 times MIC measured after 24 hrs by micro dilution method2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID1773503Selectivity index, HC50 for hemolytic activity in sheep RBC to MIC for antibacterial activity against Staphylococcus aureus ATCC29213
AID599126Antibacterial activity against Bacillus cereus clinical isolate after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID731338Partial agonist activity at recombinant human CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation at 100 uM after 5 mins by cAMP-competition binding assay relative to CP55,9402013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID1491117Anticonvulsant activity in 7-days post fertilized zebra fish larvae assessed as reduction in pentylenetetrazol-induced locomotor activity by measuring total distance traveled by larvae pretreated for 3 hrs followed by pentylenetetrazol addition measured a2017Journal of natural products, 05-26, Volume: 80, Issue:5
HPLC-Based Activity Profiling for GABA
AID1742332Antiproliferative activity against human T47D cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy.
AID599128Antibacterial activity against Shigella flexneri ATCC 12022 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID731339Partial agonist activity at recombinant human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation at 100 uM after 5 mins by cAMP-competition binding assay relative to CP55,9402013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID297145Inhibition of SARS coronavirus-induced cytopathogenicity in Vero E6 cells at 20 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID648740Antiproliferative activity against human MOLT4 cells after 48 hrs by sulforhodamine B assay2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID738972Cytotoxicity against human HepG2(2.2.15) cells after 12 days by MTT assay2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-hepatitis B virus lignans from the root of Streblus asper.
AID1190397Induction of nuclear accumulation of Nrf2 in RANKL-induced mouse RAW264.7 cells up to 20 uM after 3 hrs by Western blot analysis2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1491171Inhibition of yeast alpha-glucosidase at 1.5 uM using p-nitrophenyl-alpha-glucopyranoside as substrate measured after 30 mins relative to control
AID265953Antiviral activity against HIV1 in human PBM cells2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Facile purification of honokiol and its antiviral and cytotoxic properties.
AID1396634Binding affinity to recombinant human PARP1 expressed in baculovirus infected Sf9 cells by surface plasmon resonance analysis2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors.
AID1727640Antiproliferative activity against human NCI-H1975 cells assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID1773494Antibacterial activity against Staphylococcus aureus ATCC29213 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID341728Antibacterial activity against Shigella flexneri after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antimicrobial diterpenes from Trigonostemon chinensis.
AID70577Compound was tested for minimum inhibitory concentration against Escherichia coli ATCC 2592772001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID731341Antagonist activity at human GPR55 expressed in CHO cells assessed as inhibition of LPI-induced beta-arrestin translocation at 10 uM after 90 mins by luminescence assay2013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID613705Neurotrophic activity in isolated embryonic mouse brain Hippocampal neurons assessed as induction of neurite outgrowth at 0.01 uM after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID377348Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by broth microdilution test2005Journal of natural products, Feb, Volume: 68, Issue:2
Lignans and their degraded derivatives from Sarcostemma acidum.
AID1190395Inhibition of RANKL-induced superoxide anion production in mouse RAW264.7 cells measured after 2 hrs of RANKL stimulation2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1440410Antifungal activity against Candida albicans KCTC 1940 clinical isolates after 7 days by two fold serial dilution method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Tackling Fungal Resistance by Biofilm Inhibitors.
AID1491116Toxicity in 7-days post fertilized zebra fish larvae after 1.5 to 24 hrs by microscopic analysis2017Journal of natural products, 05-26, Volume: 80, Issue:5
HPLC-Based Activity Profiling for GABA
AID341725Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antimicrobial diterpenes from Trigonostemon chinensis.
AID1666893Antiproliferative activity against human H460 cells assessed as inhibition of cell viability at 40 uM incubated for 24 hrs by CCK-8 assay2020Bioorganic & medicinal chemistry, 03-15, Volume: 28, Issue:6
CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis.
AID377349Antimicrobial activity against Candida albicans ATCC 1600 after 48 hrs by broth microdilution test2005Journal of natural products, Feb, Volume: 68, Issue:2
Lignans and their degraded derivatives from Sarcostemma acidum.
AID1762958Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as inhibition of cell proliferation measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by EdU incorporation based analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID611251Octanol-water partition coefficient, log P of the compound2011Journal of medicinal chemistry, Aug-11, Volume: 54, Issue:15
Modulation of GABAA-receptors by honokiol and derivatives: subtype selectivity and structure-activity relationship.
AID337441Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio
AID1773495Antibacterial activity against Enterococcus faecalis ATCC29212 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID297146Inhibition of SARS coronavirus-induced cytopathogenicity in Vero E6 cells at 10 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID599123Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID1762950Effect on Bax protein expression in cardiac fibroblasts (unknown origin) at 5 to 20 uM incubated for 24 hrs by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID731342Antagonist activity at human GPR55 expressed in CHO cells assessed as inhibition of LPI-induced beta-arrestin translocation after 90 mins by luminescence assay2013ACS medicinal chemistry letters, Jan-10, Volume: 4, Issue:1
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
AID1773497Antibacterial activity against Micrococcus luteus assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID341729Antibacterial activity against Pseudomonas aeruginosa after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antimicrobial diterpenes from Trigonostemon chinensis.
AID1190399Antiosteoclast activity in mouse RAW264.7 cells assessed as reduction of RANKL-induced osteoclasts differentiation by measuring TRAP activity after 5 days in presence of tin protoporphyrin 9 (SnPP)2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID341724Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antimicrobial diterpenes from Trigonostemon chinensis.
AID1762956Agonist activity at human recombinant ALDH2 measured after 1 hr2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1762961Effect on Bcl2 protein expression in cardiac fibroblasts (unknown origin) measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1190396Induction of HO-1 protein expression in RANKL-induced mouse RAW264.7 cells up to 20 uM after 3 hrs by Western blot analysis2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1405915Drug level in Sprague-Dawley rat feces treated with Magnolol-4'-O-beta-D-glucopyranoside at 100 mg/kg, po by UPLC-IT-TOF-MS analysis2018European journal of medicinal chemistry, Aug-05, Volume: 156Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
AID1190393Inhibition of RANKL-stimulated p38 MAPK phosphorylation in mouse RAW264.7 cells at 20 uM by Western blotting analysis2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID550841Antibacterial activity against Pseudomonas aeruginosa ATCC 14502 assessed as inhibition of visible growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Ring A-seco triterpenoids with antibacterial activity from Dysoxylum hainanense.
AID613711Neurotrophic activity in isolated embryonic mouse embryonic Cortical neurons assessed as induction of neurite outgrowth at 1 uM after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID341730Antibacterial activity against Bacillus subtilis CMCC 63501 after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antimicrobial diterpenes from Trigonostemon chinensis.
AID1727644Antiproliferative activity against human NCI-H1650 cells expressing EGFR mutant assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
AID613706Neurotrophic activity in isolated embryonic mouse brain Hippocampal neurons assessed as induction of neurite outgrowth at 0.1 uM after 48 hrs relative to control2011Bioorganic & medicinal chemistry letters, Aug-15, Volume: 21, Issue:16
Hippocampal and cortical neuronal growth mediated by the small molecule natural product clovanemagnolol.
AID1666894Antiproliferative activity against human A549 cells assessed as inhibition of cell viability at 40 uM incubated for 24 hrs by CCK-8 assay2020Bioorganic & medicinal chemistry, 03-15, Volume: 28, Issue:6
CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis.
AID599130Antibacterial activity against Serratia marcescens ATCC 25419 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID1361279Antiproliferative activity against human NCI-H358 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID297151Selectivity index, Ratio of CC50 for Vero E6 cells to EC50 for SARS coronavirus2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID550838Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of visible growth2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Ring A-seco triterpenoids with antibacterial activity from Dysoxylum hainanense.
AID666150Inhibition of PA endonuclease at 10 uM2011PloS one, , Volume: 6, Issue:5
Anti-influenza activity of marchantins, macrocyclic bisbibenzyls contained in liverworts.
AID1762959Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in CDK4 protein expression measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by western blot analysis2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID1181044Inhibition of LPS-induced IL-1beta production in mouse RAW264.7 cells after 24 hrs by ELISA2014Journal of natural products, Jul-25, Volume: 77, Issue:7
2-Phenoxychromones and prenylflavonoids from Epimedium koreanum and their inhibitory effects on LPS-induced nitric oxide and interleukin-1β production.
AID341727Antibacterial activity against Escherichia coli after 18 hrs2008Journal of natural products, Aug, Volume: 71, Issue:8
Antimicrobial diterpenes from Trigonostemon chinensis.
AID1405806Agonist activity at human MT1 receptor expressed in HEK293 cells at 1 mM after 24 hrs by Fluo-8 dye-based calcium assay relative to control2018European journal of medicinal chemistry, Aug-05, Volume: 156Synthesis and biological evaluation of magnolol derivatives as melatonergic receptor agonists with potential use in depression.
AID1361277Antiproliferative activity against human PC9 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID337443Inhibition of DMBA-induced/TPA-promoted carcinogenesis in ICR mouse assessed as reduction of skin papillomas per mouse at 85 nmol administered twice weekly after 1 week of initiation measured after 20 weeks
AID1190394Inhibition of RANKL-induced H2O2 production in mouse RAW264.7 cells measured after 2 hrs of RANKL stimulation2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID648730Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by micro dilution method2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID297148Inhibition of SARS virus-induced cytopathogenicity in Vero E6 cells at 1 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
AID1762963Anti-myocardial fibrosis activity against cardiac fibroblasts (unknown origin) assessed as reduction in collagen synthesis by measuring reduction in type1 collagen protein expression measured after 24 hrs in presence of ALDH2 inhibitor, daidzin by western2021Bioorganic & medicinal chemistry letters, 07-01, Volume: 43Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.
AID337435Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells at 100 molar ratio after 48 hrs relative to TPA
AID738968Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication after 72 hrs by PCR analysis2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-hepatitis B virus lignans from the root of Streblus asper.
AID292082Antiproliferative activity against mouse SVR cells at 15 ug/mL after 72 hrs2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID1742336Antiproliferative activity against human HEK293 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy.
AID1396632Binding affinity to recombinant human CK2alpha/beta expressed in Escherichia coli by surface plasmon resonance analysis2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors.
AID1491172Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-glucopyranoside as substrate measured after 30 mins
AID265951Cytotoxicity against Vero cells2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Facile purification of honokiol and its antiviral and cytotoxic properties.
AID1773501Antibacterial activity against Salmonella enterica 8389 assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID1891770Positive allosteric modulation of GABAA alpha1beta2gamma2 receptor (unknown origin) stably expressed in CHO cells assessed as activation of GABA-induced response in presence of GABA by FLIPR assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Clerodane Diterpenes from
AID1552550Partition coefficient, log P of the compound2019Bioorganic & medicinal chemistry, 08-15, Volume: 27, Issue:16
Anti-proliferative activity and structure-activity relationship of honokiol derivatives.
AID599125Antibacterial activity against Bacillus subtilis ATCC 6633 after 18 hrs by microdilution assay2011Journal of natural products, May-27, Volume: 74, Issue:5
Onoceranoid-type triterpenoids from Lansium domesticum.
AID1190400Inhibition of NFATc1 expression in RANKL-induced mouse RAW264.7 cells at 20 uM after 24 hrs by immunofluorescence staining2015Journal of natural products, Jan-23, Volume: 78, Issue:1
Magnolol Inhibits RANKL-induced osteoclast differentiation of raw 264.7 macrophages through heme oxygenase-1-dependent inhibition of NFATc1 expression.
AID1361274Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Aug-05, Volume: 156Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
AID1773496Antibacterial activity against Bacillus subtilis assessed as inhibition of visible growth incubated for 16 to 18 hrs by CLSI method
AID265952Cytotoxicity against human CEM cells2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Facile purification of honokiol and its antiviral and cytotoxic properties.
AID1742335Antiproliferative activity against human A549 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay2020European journal of medicinal chemistry, Nov-01, Volume: 205Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy.
AID648734Antibacterial activity against methicillin-resistant Staphylococcus aureus 15187 treated for 24 hrs followed by compound treated at 2 to 16 times MIC measured after 24 hrs by micro dilution method2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID1666898Inhibition of colony formation in human H460 cells at 20 uM incubated for 48 hrs and measured after 10 days culturing in normal media by Giemsa staining based inverted microscopy2020Bioorganic & medicinal chemistry, 03-15, Volume: 28, Issue:6
CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis.
AID648732Antibacterial activity against vancomycin-resistant Enterococcus after 24 hrs by micro dilution method2012European journal of medicinal chemistry, May, Volume: 51Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
AID292084Cytotoxicity against human PBM cells2007Bioorganic & medicinal chemistry letters, Aug-15, Volume: 17, Issue:16
Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
AID1440412Antifungal activity against Trichophyton mentagrophytes KCTC 6077 clinical isolates after 7 days by two fold serial dilution method2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Tackling Fungal Resistance by Biofilm Inhibitors.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2011PloS one, , Volume: 6, Issue:11
Molecular determinants of magnolol targeting both RXRα and PPARγ.
AID1799559Binding Assay from Article 10.1016/j.chembiol.2011.05.012: \\Mechanisms of Osteoclastogenesis Inhibition by a Novel Class of Biphenyl-Type Cannabinoid CB(2) Receptor Inverse Agonists.\\2011Chemistry & biology, Aug-26, Volume: 18, Issue:8
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (544)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (2.57)18.7374
1990's44 (8.09)18.2507
2000's137 (25.18)29.6817
2010's252 (46.32)24.3611
2020's97 (17.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.93 (24.57)
Research Supply Index6.33 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index74.34 (26.88)
Search Engine Supply Index3.28 (0.95)

This Compound (32.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.18%)5.53%
Reviews22 (3.93%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other537 (95.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]